PCRX - Pacira BioSciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Pacira BioSciences, Inc.

5 Sylvan Way
Suite 300
Parsippany, NJ 07054
United States

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees518

Key Executives

NameTitlePayExercisedYear Born
Mr. David M. StackChairman & CEO1.5M4.18M1950
Mr. Charles A. Reinhart III, CPA, M.B.A.Chief Financial Officer644.22kN/A1961
Ms. Kristen WilliamsChief Admin. Officer & Sec.732.61kN/A1974
Dr. Richard Scranton M.D., MPHChief Medical Officer733.74kN/A1967
Mr. Dennis McLoughlinChief Commercial Officer535.87kN/A1966
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. has collaboration with Aetna. Pacira BioSciences, Inc. was founded in 2006 and is based in Parsippany, New Jersey.

Corporate Governance

Pacira BioSciences, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 6. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 7; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.